Sekisui and Aptitude Partner on POC, At-Home COVID Tests
Sekisui formalized an exclusive distribution agreement with Aptitude Medical Systems to sell the Aptitude Metrix COVID Test in the U.S.
Read MorePosted by Andy Lundin | Jan 3, 2024 | Covid 19, POC Rapid Assays |
Sekisui formalized an exclusive distribution agreement with Aptitude Medical Systems to sell the Aptitude Metrix COVID Test in the U.S.
Read MorePosted by Andy Lundin | Jan 2, 2024 | Diagnostic Technologies |
Daxor submitted its next-generation blood volume analyzer—Daxor BVA—to the U.S. FDA via the 510(k)/CLIA-waiver dual submission pathway.
Read MorePosted by Andy Lundin | Dec 27, 2023 | Covid 19 |
Co-Diagnostics submitted its Co-Dx PCR COVID-19 test for review by the U.S. FDA for Emergency Use Authorization (EUA).
Read MorePosted by Andy Lundin | Dec 27, 2023 | Sexually Transmitted Diseases |
The company began commercial shipments as part of the initial purchase order for 2.5 million tests, with further shipments scheduled.
Read MorePosted by Andy Lundin | Dec 21, 2023 | Molecular Diagnostics, Sexually Transmitted Diseases |
QuidelOrtho received 510(K) clearance from the FDA for its innovative Savanna PCR platform and Savanna HSV 1+2/VZV in vitro diagnostic test
Read More